| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 1,218,000 | 1,219,000 | 1,118,000 | 1,333,000 | | Cost of Revenue | (512,000) | 1,371,000 | 440,000 | 2,546,000 | | | Gross Profit | 1,730,000 | (152,000) | 678,000 | (1,213,000) | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 1,561,000 | (336,000) | 525,000 | (1,468,000) | | Non Recurring | 2,000 | 5,000 | 17,000 | 109,000 | | Others | 82,000 | 79,000 | 77,000 | 81,000 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 85,000 | 100,000 | 59,000 | 65,000 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (27,000) | (34,000) | (5,000) | (83,000) | | Earnings Before Interest And Taxes | 55,000 | 69,000 | 49,000 | (16,000) | | Interest Expense | 60,000 | 53,000 | 43,000 | 60,000 | | Income Before Tax | (5,000) | 16,000 | 6,000 | (76,000) | | Income Tax Expense | (46,000) | (115,000) | 1,000 | (30,000) | | Minority Interest | 2,000 |
-
|
-
| 1,000 | | | | Net Income From Continuing Ops | 43,000 | 131,000 | 5,000 | (45,000) | | | Non-recurring Events | | Discontinued Operations | (1,000) | 3,000 | (1,000) | 124,000 | | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 42,000 | 134,000 | 4,000 | 79,000 | | Preferred Stock And Other Adjustments | (2,000) |
-
| 2,000 |
-
| | | Net Income Applicable To Common Shares | $40,000 | $134,000 | $6,000 | $79,000 |
|
0.83% Nasdaq 0.00%
Income Statement
